HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert F Hobbs Selected Research

Samarium-153

7/2011A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.
12/2010Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.
6/2009Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert F Hobbs Research Topics

Disease

31Neoplasms (Cancer)
06/2022 - 10/2008
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2009
7Neoplasm Metastasis (Metastasis)
06/2020 - 10/2008
4Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2022 - 02/2013
4Breast Neoplasms (Breast Cancer)
12/2017 - 10/2008
4Thyroid Neoplasms (Thyroid Cancer)
01/2017 - 03/2009
4Osteosarcoma (Osteogenic Sarcoma)
11/2015 - 06/2009
3Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2013 - 03/2010
2Hepatocellular Carcinoma (Hepatoma)
10/2016 - 02/2013
2Neoplasm Micrometastasis
10/2016 - 12/2009
1Liver Neoplasms (Liver Cancer)
10/2016
1Colorectal Neoplasms (Colorectal Cancer)
12/2015
1Hodgkin Disease (Hodgkin's Disease)
07/2015
1Graves Disease (Basedow Disease)
05/2014
1Adenocarcinoma
12/2013
1Triple Negative Breast Neoplasms
10/2013
1Carcinoma (Carcinomatosis)
10/2008
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2008
1Kaposi Sarcoma (Kaposi's Sarcoma)
10/2008

Drug/Important Bio-Agent (IBA)

14RadiopharmaceuticalsIBA
06/2022 - 10/2008
7AntigensIBA
01/2021 - 10/2008
6Radioisotopes (Radionuclides)IBA
06/2022 - 05/2012
4Biological ProductsIBA
01/2014 - 03/2010
3Somatostatin Receptors (Somatostatin Receptor)IBA
06/2022 - 01/2018
3Peptides (Polypeptides)IBA
12/2015 - 02/2013
3Samarium-153IBA
07/2011 - 06/2009
2Peptide Receptors (Peptide Receptor)IBA
06/2022 - 01/2022
2Lutetium-177IBA
06/2022 - 01/2022
2Radium-223IBA
06/2020 - 05/2016
2LuciferasesIBA
01/2020 - 10/2016
2AntibodiesIBA
12/2017 - 05/2014
2Monoclonal AntibodiesIBA
12/2015 - 12/2009
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2015 - 12/2010
2phosphonic acidIBA
02/2012 - 06/2009
2Bortezomib (Velcade)FDA Link
06/2011 - 10/2008
2EnzymesIBA
06/2011 - 10/2008
2samarium Sm-153 lexidronam (Quadramet)FDA Link
12/2010 - 06/2009
1Hormones (Hormone)IBA
06/2020
1AndrogensIBA
06/2020
12- (3- (1- carboxy- 5- (4- iodobenzylamino)pentyl)ureido)pentanedioic acidIBA
01/2020
1AcidsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1PSMA I&TIBA
11/2019
1177Lu-PSMA-617IBA
11/2019
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018
1gallium Ga 68 dotatateIBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
12/2017
1IsotopesIBA
02/2017
1Thyroid HormonesIBA
01/2017
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2017
1Thyrotropin AlfaFDA LinkGeneric
01/2017
1Urea (Carbamide)FDA LinkGeneric
10/2016
1DNA (Deoxyribonucleic Acid)IBA
10/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
10/2013
1phosphoric acid (orthophosphoric acid)FDA Link
12/2010
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
12/2010
1A-factor (Streptomyces)IBA
03/2010
1SolutionsIBA
03/2009
1iodouracilIBA
10/2008
1fialuridineIBA
10/2008
1Thymidine KinaseIBA
10/2008

Therapy/Procedure

28Therapeutics
06/2022 - 10/2008
9Radiotherapy
01/2021 - 10/2008
3Castration
01/2022 - 05/2016
3Radioimmunotherapy
12/2015 - 12/2009
2Drug Therapy (Chemotherapy)
05/2014 - 06/2009
1Injections
01/2017
1Microspheres (Microsphere)
10/2016
1Aftercare (After-Treatment)
12/2014
1Pancreaticoduodenectomy
12/2013
1Immunotherapy
10/2008